What is Protokinetix Inc's earnings per share (EPS)?

Protokinetix Inc (PKTX) reported diluted earnings per share of $0.00 for fiscal year 2024. This represents a 100.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Protokinetix Inc Financials

PKTX

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

This page shows Protokinetix Inc (PKTX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 25 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 16/100

Based on FY2024 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Protokinetix Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Leverage

Protokinetix Inc carries a low D/E ratio of 0.36, meaning only $0.36 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 95/100, indicating a strong balance sheet with room for future borrowing.

Returns

Protokinetix Inc generates a -106.5% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -95.3% the prior year.

Piotroski F-Score Weak

2/9

Protokinetix Inc passes 2 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).

Earnings Quality Low Quality

0.61x

For every $1 of reported earnings, Protokinetix Inc generates $0.61 in operating cash flow (-$223K OCF vs -$364K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

-$364K

YoY+12.3%

Protokinetix Inc reported -$364K in net income in fiscal year 2024. This represents an increase of 12.3% from the prior year.

EPS (Diluted)

$0.00

YoY+100.0%

Protokinetix Inc earned $0.00 per diluted share (EPS) in fiscal year 2024. This represents an increase of 100.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

N/A

Dividends Per Share

N/A

Shares Outstanding

372M

YoY+7.4%

5Y CAGR+6.2%

10Y CAGR+7.8%

Protokinetix Inc had 372M shares outstanding in fiscal year 2024. This represents an increase of 7.4% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

-106.5%

YoY-11.1pp

Protokinetix Inc's ROE was -106.5% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 11.1 percentage points from the prior year.

Capital Allocation

R&D Spending

$100K

YoY-11.4%

5Y CAGR-23.1%

10Y CAGR+21.9%

Protokinetix Inc invested $100K in research and development in fiscal year 2024. This represents a decrease of 11.4% from the prior year.

Share Buybacks

N/A

Capital Expenditures

N/A

PKTX Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$100K-11.4%	$112K-74.9%	$449K+3.0%	$436K-17.3%	$527K+42.7%	$370K
SG&A Expenses	$61K-38.3%	$100K-38.8%	$163K-48.7%	$317K+51.7%	$209K-25.5%	$280K
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	$0
Income Tax	$0	$0	N/A	$0	$0	$0
Net Income	-$364K+12.3%	-$415K+78.2%	-$1.9M	N/A	N/A	N/A
EPS (Diluted)	$0.00+100.0%	$-0.010.0%	$-0.01	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$24K-0.9%	$24K-27.8%	$34K	N/A	$21K0.0%	$21K-42.7%	$37K	N/A
SG&A Expenses	$16K+15.1%	$14K-4.4%	$15K	N/A	$16K+23.0%	$13K-6.5%	$14K	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$85K+6.8%	-$91K+6.8%	-$98K	N/A	-$85K+0.6%	-$85K+7.6%	-$92K	N/A
EPS (Diluted)	$0.00	$0.00	$0.00	N/A	$0.00	$0.00	$0.00	N/A

PKTX Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$466K-3.0%	$481K+3.8%	$463K+3.7%	$446K-4.9%	$469K-19.9%	$586K
Current Assets	N/A	$21K-19.3%	$27K-68.2%	$84K-57.0%	$194K-48.6%	$378K
Cash & Equivalents	N/A	$20K-20.1%	$26K-55.6%	$58K-70.2%	$193K-48.7%	$377K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$124K+177.5%	$45K+7.6%	$42K-55.5%	$93K+107.5%	$45K+76.2%	$26K
Current Liabilities	$124K+177.5%	$45K+7.6%	$42K-55.5%	$93K+107.5%	$45K	$0
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$342K-21.5%	$436K+3.4%	$421K+19.4%	$353K-16.8%	$424K-24.3%	$560K
Retained Earnings	-$48.2M-0.8%	-$47.9M-0.9%	-$47.4M-4.2%	-$45.5M-5.4%	-$43.2M-21.5%	-$35.5M

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Total Assets	$478K+0.7%	$474K-10.3%	$529K+13.4%	$466K-2.7%	$479K+1.2%	$474K+2.6%	$461K-4.0%	$481K
Current Assets	N/A	N/A	N/A	N/A	$7K+107.4%	$3K-16.4%	$4K-81.9%	$21K
Cash & Equivalents	$607+442.0%	$112-99.8%	$49K	N/A	$6K+158.6%	$2K-22.4%	$3K-86.1%	$20K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$227K+52.4%	$149K-2.1%	$152K+22.7%	$124K+41.4%	$88K+49.3%	$59K-13.0%	$68K+51.2%	$45K
Current Liabilities	$227K+52.4%	$149K-2.1%	$152K+22.7%	$124K+41.4%	$88K+49.3%	$59K-13.0%	$68K+51.2%	$45K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$250K-23.0%	$325K-13.6%	$376K+10.0%	$342K-12.6%	$392K-5.6%	$415K+5.3%	$394K-9.6%	$436K
Retained Earnings	-$48.5M-0.2%	-$48.4M-0.2%	-$48.3M-0.2%	-$48.2M-0.2%	-$48.1M-0.2%	-$48.0M-0.2%	-$48.0M-0.2%	-$47.9M

PKTX Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	-$223K+40.7%	-$376K+53.3%	-$805K+9.6%	-$890K-1.0%	-$881K-3.6%	-$851K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$58K+1.9%	-$59K+55.2%	-$132K-45.1%	-$91K-29.6%	-$70K-180.5%	-$25K
Financing Cash Flow	$256K-40.5%	$430K-52.5%	$905K+7.1%	$845K+10.1%	$768K-31.3%	$1.1M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Operating Cash Flow	-$4K+95.1%	-$80K-54.0%	-$52K-14.9%	-$45K-15.7%	-$39K+51.6%	-$81K-39.8%	-$58K+25.3%	-$77K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$6K-16.4%	-$5K+81.4%	-$26K-402.5%	-$5K+70.4%	-$17K+32.5%	-$26K-164.8%	-$10K+60.3%	-$25K
Financing Cash Flow	$10K-71.8%	$36K-73.1%	$132K+230.0%	$40K-33.3%	$60K-43.4%	$106K+112.0%	$50K-54.5%	$110K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

PKTX Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	-106.5%-11.1pp	-95.3%+357.4pp	-452.7%	N/A	N/A	N/A
Return on Assets	-78.1%+8.3pp	-86.5%+325.6pp	-412.1%	N/A	N/A	N/A
Current Ratio	N/A	0.48-0.2	0.64-0.3	0.90-3.4	4.33	N/A
Debt-to-Equity	0.36+0.3	0.100.0	0.10-0.2	0.26+0.2	0.11+0.1	0.05
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	-33.9%-5.9pp	-28.0%-2.0pp	-25.9%	N/A	-21.6%-1.1pp	-20.5%+2.9pp	-23.4%	N/A
Return on Assets	-17.8%+1.4pp	-19.2%-0.7pp	-18.5%	N/A	-17.6%+0.3pp	-18.0%+2.0pp	-19.9%	N/A
Current Ratio	N/A	N/A	N/A	N/A	0.08+0.0	0.060.0	0.06-0.4	0.48
Debt-to-Equity	0.91+0.4	0.46+0.1	0.40+0.0	0.36+0.1	0.22+0.1	0.14-0.0	0.17+0.1	0.10
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Avenue Therapeutics Inc ATXI

$2.8M

Restart Life NMLSF

$2.9M

Mosaic Immunoengineering Inc CPMV

$2.4M

Mynd Life Scienc MYNDF

$895K

Zelira Therapeutics Limited ZLDAF

$3.0M

Frequently Asked Questions

Is Protokinetix Inc profitable?

No, Protokinetix Inc (PKTX) reported a net income of -$364K in fiscal year 2024.

What is Protokinetix Inc's return on equity (ROE)?

Protokinetix Inc (PKTX) has a return on equity of -106.5% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is Protokinetix Inc's operating cash flow?

Protokinetix Inc (PKTX) generated -$223K in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Protokinetix Inc's total assets?

Protokinetix Inc (PKTX) had $466K in total assets as of fiscal year 2024, including both current and long-term assets.

How much does Protokinetix Inc spend on research and development?

Protokinetix Inc (PKTX) invested $100K in research and development during fiscal year 2024.

How many shares does Protokinetix Inc have outstanding?

Protokinetix Inc (PKTX) had 372M shares outstanding as of fiscal year 2024.

What is Protokinetix Inc's debt-to-equity ratio?

Protokinetix Inc (PKTX) had a debt-to-equity ratio of 0.36 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Protokinetix Inc's return on assets (ROA)?

Protokinetix Inc (PKTX) had a return on assets of -78.1% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Protokinetix Inc's Piotroski F-Score?

Protokinetix Inc (PKTX) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Protokinetix Inc's earnings high quality?

Protokinetix Inc (PKTX) has an earnings quality ratio of 0.61x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Protokinetix Inc?

Protokinetix Inc (PKTX) scores 16 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.